IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Nucleic Acid Therapeutics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

3.95

h-Index

2022-2023

 73

Rank

2022-2023

 2164

SJR

2022-2023

 1.490

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Nucleic Acid Therapeutics
Abbreviation Nucleic Acid Ther.
Publication Type Journal
Subject Area, Categories, Scope Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)
h-index 73
Overall Rank/Ranking 2164
SCImago Journal Rank (SJR) 1.490
Impact Score 3.95
Publisher Mary Ann Liebert Inc.
Country United States
ISSN 21593345, 21593337
Best Quartile Q1
Coverage History 2011-2022




About Nucleic Acid Therapeutics


Nucleic Acid Therapeutics is a journal covering the technologies/fields/categories related to Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). It is published by Mary Ann Liebert Inc.. The overall rank of Nucleic Acid Therapeutics is 2164. According to SCImago Journal Rank (SJR), this journal is ranked 1.490. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 73. The best quartile for this journal is Q1.

The ISSN of Nucleic Acid Therapeutics journal is 21593345, 21593337. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nucleic Acid Therapeutics is cited by a total of 472 articles during the last 3 years (Preceding 2022).


Nucleic Acid Therapeutics Impact IF 2022-2023


The Impact IF 2022 of Nucleic Acid Therapeutics is 3.95, which is computed in 2023 as per its definition. Nucleic Acid Therapeutics IF is decreased by a factor of 0.67 and approximate percentage change is -14.5% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Nucleic Acid Therapeutics Impact IF 2023 Prediction


Impact IF 2022 of Nucleic Acid Therapeutics is 3.95. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Nucleic Acid Therapeutics. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 3.95
2021 4.62
2020 4.96
2019 5.61
2018 3.88
2017 2.46
2016 2.54
2015 2.97
2014 3.09

Nucleic Acid Therapeutics h-index


  Table Setting

Nucleic Acid Therapeutics has an h-index of 73. It means 73 articles of this journal have more than 73 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Nucleic Acid Therapeutics ISSN


The ISSN of Nucleic Acid Therapeutics is 21593345, 21593337. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Nucleic Acid Therapeutics Rank and SCImago Journal Rank (SJR)


The overall rank of Nucleic Acid Therapeutics is 2164. According to SCImago Journal Rank (SJR), this journal is ranked 1.490. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Nucleic Acid Therapeutics by Year


Year SJR
2023/2024 Coming Soon
2022 1.490
2021 1.566
2020 2.255
2019 2.176
2018 1.488
2017 1.794
2016 1.223
2015 1.618
2014 1.239

Ranking of Nucleic Acid Therapeutics by Year


Year Ranking
2023/2024 Coming Soon
2022 2164
2021 1950
2020 1091
2019 1135
2018 2275
2017 1669
2016 3263
2015 2099
2014 3161

Nucleic Acid Therapeutics Publisher


Table Setting

Nucleic Acid Therapeutics is published by Mary Ann Liebert Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2011-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Nucleic Acid Therapeutics is Nucleic Acid Ther.. This abbreviation ('Nucleic Acid Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Nucleic Acid Therapeutics


If your research field is/are related to Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Nucleic Acid Therapeutics?

Nucleic Acid Therapeutics latest impact IF is 3.95. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.61 (2019) and 2.46 (2017), respectively, in the last 9 years. Moreover, its average IS is 3.79 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Nucleic Acid Therapeutics?

The Nucleic Acid Therapeutics has an SJR (SCImago Journal Rank) of 1.490, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.255 in 2020 and the lowest being 1.223 in 2016. Furthermore, the average SJR of the Nucleic Acid Therapeutics over the previous 9-year period stands at 3.79.


What's the latest h-index of the Nucleic Acid Therapeutics?

The latest h-index of the Nucleic Acid Therapeutics is 73.


Who's the publisher of the Nucleic Acid Therapeutics?

The Nucleic Acid Therapeutics is published by the Mary Ann Liebert Inc., with its country of publication being the United States.


What's the current ranking of the Nucleic Acid Therapeutics?

The Nucleic Acid Therapeutics is currently ranked 2164 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1091 in 2020 and its lowest position of 3263 in 2016.


What's the abbreviation or short name for the Nucleic Acid Therapeutics?

The standard ISO4 abbreviation for the Nucleic Acid Therapeutics is Nucleic Acid Ther..


Is the "Nucleic Acid Therapeutics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Nucleic Acid Therapeutics is classified as a journal that the Mary Ann Liebert Inc. publishes.


What's the scope or major areas of the Nucleic Acid Therapeutics?

The Nucleic Acid Therapeutics encompasses the following areas:

  • Biochemistry
  • Drug Discovery
  • Genetics
  • Molecular Biology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Nucleic Acid Therapeutics?

The Nucleic Acid Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 21593345, 21593337.


What's the best quartile of the Nucleic Acid Therapeutics?

The best quartile for the Nucleic Acid Therapeutics is Q1 (2022).


What's the coverage history of the Nucleic Acid Therapeutics?

The Nucleic Acid Therapeutics coverage history can be summarized as follows: 2011-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Journal of Competition Law and Economics journal 14815 Oxford University Press 29 0.72
Mathematical Modelling and Analysis journal 11315 Vilnius Gediminas Technical University 27 1.75
Discourse journal 6621 Routledge 59 2.11
International Journal of Applied Linguistics journal 7321 Wiley-Blackwell Publishing Ltd 51 2.00
British Journal of Special Education journal 12024 Wiley-Blackwell Publishing Ltd 42 1.24
European Journal of Education journal 6079 Wiley-Blackwell Publishing Ltd 53 2.31
Libyan Studies journal 16122 Cambridge University Press 8 0.45
Journal des Professionnels de l'Enfance journal 27577 TPMA 2 0.00

Check complete list




Year wise Impact Score (IS) of Nucleic Acid Therapeutics

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.95
2021 4.62
2020 4.96
2019 5.61
2018 3.88
2017 2.46
2016 2.54
2015 2.97
2014 3.09



Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biophysics
Annual Reviews Inc. | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Genetics

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United States

Genome Biology
BioMed Central Ltd. | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Nucleic Acids Research
Oxford University Press | United Kingdom

Annual Review of Genetics
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Cell Host and Microbe
Cell Press | United States

Cell Metabolism
Cell Press | United States

Molecular Cell
Cell Press | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All